TREM2 and early-onset autosomal dominant Alzheimer disease: The R47H variant of the triggering receptor expressed on myeloid cells 2 (TREM2) is a risk factor for Alzheimer’s disease in humans and leads to lower bone mass accrual in female but not male 12-mo-old mice.